Nitric Oxide Synthase Inhibition Protects Against Rotenone-Induced Neurodegeneration in vivo
暂无分享,去创建一个
[1] M. Afify,et al. Modafinil Alleviates Rotenone-Induced Neurochemical changes and Striatal Neurodegeneration via Inhibiting Oxidative Stress and Neuroinflammation , 2020, Egyptian Journal of Chemistry.
[2] J. Jankovic,et al. Parkinson’s disease: etiopathogenesis and treatment , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.
[3] E. Youness,et al. Neuroprotective Effects of the Glutathione Precursor N-Acetylcysteine against Rotenone-Induced Neurodegeneration , 2019, Reactive Oxygen Species.
[4] F. N. Emamzadeh,et al. Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors , 2018, Front. Neurosci..
[5] A. Abramov,et al. Role of mitochondrial ROS in the brain: from physiology to neurodegeneration , 2018, FEBS letters.
[6] E. Youness,et al. Neuroprotection by misoprostol against rotenone-induced neurotoxicity in rat brain , 2018 .
[7] E. Youness,et al. The effect of cannabis on oxidative stress and neurodegeneration induced by intrastriatal rotenone injection in rats , 2015, Comparative Clinical Pathology.
[8] J. Duarte,et al. Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases--a mechanistic approach. , 2014, Toxicology letters.
[9] J. Hussein,et al. Nigrostriatal damage after systemic rotenone and/or lipopolysaccharide and the effect of cannabis , 2014, Comparative Clinical Pathology.
[10] Peter E. Czabotar,et al. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy , 2013, Nature Reviews Molecular Cell Biology.
[11] J. Sinsheimer,et al. Household organophosphorus pesticide use and Parkinson's disease. , 2013, International journal of epidemiology.
[12] J. Sinsheimer,et al. Functional paraoxonase 1 variants modify the risk of Parkinson's disease due to organophosphate exposure. , 2013, Environment international.
[13] M. Varghese,et al. Nitric oxide synthase inhibitors protect against rotenone-induced, oxidative stress mediated parkinsonism in rats , 2013, Neurochemistry International.
[14] S. Koifman,et al. Pesticide exposure and Parkinson's disease: epidemiological evidence of association. , 2012, Neurotoxicology.
[15] Chi Li,et al. The Bcl-2 proteins Noxa and Bcl-xL co-ordinately regulate oxidative stress-induced apoptosis. , 2012, The Biochemical journal.
[16] U. Förstermann,et al. Nitric oxide synthases: regulation and function. , 2012, European heart journal.
[17] J. Blesa,et al. Classic and New Animal Models of Parkinson's Disease , 2012, Journal of biomedicine & biotechnology.
[18] T. Ng,et al. Baicalein antagonizes rotenone-induced apoptosis in dopaminergic SH-SY5Y cells related to Parkinsonism , 2012, Chinese Medicine.
[19] H. Adami,et al. Epidemiology and etiology of Parkinson’s disease: a review of the evidence , 2011, European Journal of Epidemiology.
[20] Tatiana Foroud,et al. Genetics of Parkinson disease , 2004, Genetics in Medicine.
[21] Guy C. Brown,et al. Nitric oxide and neuronal death. , 2010, Nitric oxide : biology and chemistry.
[22] D. Green,et al. The BCL-2 family reunion. , 2010, Molecular cell.
[23] H. Park,et al. Tranexamic acid protects against rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. , 2009, Toxicology.
[24] Victor Tapias,et al. A highly reproducible rotenone model of Parkinson's disease , 2009, Neurobiology of Disease.
[25] Nguyen Dang Hung,et al. Oxidative inactivation of lactonase activity of purified human paraoxonase 1 (PON1). , 2009, Biochimica et biophysica acta.
[26] M. Watabe,et al. Mitochondrial Complex I Inhibitor Rotenone Inhibits and Redistributes Vesicular Monoamine Transporter 2 via Nitration in Human Dopaminergic SH-SY5Y Cells , 2008, Molecular Pharmacology.
[27] J. Andersen,et al. Oxidative and nitrative protein modifications in Parkinson's disease. , 2008, Free radical biology & medicine.
[28] Eden R Martin,et al. Pesticide exposure and risk of Parkinson's disease: A family-based case-control study , 2008, BMC neurology.
[29] S. Moncada,et al. Nitric oxide, cell bioenergetics and neurodegeneration , 2006, Journal of neurochemistry.
[30] A. Vinogradov,et al. Generation of superoxide by the mitochondrial Complex I. , 2006, Biochimica et biophysica acta.
[31] V. Nair,et al. The thiobarbituric acid test for lipid peroxidation: Structure of the adduct with malondialdehyde , 1984, Lipids.
[32] D. Sok,et al. Preferential inhibition of paraoxonase activity of human paraoxonase 1 by negatively charged lipids Published, JLR Papers in Press, September 16, 2004. DOI 10.1194/jlr.M400144-JLR200 , 2004, Journal of Lipid Research.
[33] Werner J. Schmidt,et al. Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain , 2004, Experimental Neurology.
[34] T. Araki,et al. Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study , 2004, European Neuropsychopharmacology.
[35] B. La Du,et al. Pharmacogenetics of paraoxonases: a brief review , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.
[36] Todd B. Sherer,et al. Mechanism of Toxicity in Rotenone Models of Parkinson's Disease , 2003, The Journal of Neuroscience.
[37] Joseph Jankovic,et al. Role of nitric oxide in rotenone‐induced nigro‐striatal injury , 2003, Journal of neurochemistry.
[38] P. Boon,et al. The pathophysiology of motor symptoms in Parkinson's disease. , 2003, Acta neurologica Belgica.
[39] J. Paul Robinson,et al. Mitochondrial Complex I Inhibitor Rotenone Induces Apoptosis through Enhancing Mitochondrial Reactive Oxygen Species Production* , 2003, The Journal of Biological Chemistry.
[40] Todd B. Sherer,et al. Subcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and α-Synuclein Aggregation , 2003, Experimental Neurology.
[41] P. Hien,et al. ROTENONE - POTENTIAL AND PROSPECT FOR SUSTAINABLE AGRICULTURE , 2003 .
[42] Y. Vodovotz,et al. The Chemical Biology of Nitric Oxide , 2002 .
[43] B. Trump,et al. BCL-2 is involved in preventing oxidant-induced cell death and in decreasing oxygen radical production , 2001, Redox report : communications in free radical research.
[44] M. Rigoulet,et al. Mitochondrial ROS Metabolism: Modulation by Uncoupling Proteins , 2001, IUBMB life.
[45] S. Dunnett,et al. The staircase test of skilled reaching in mice , 2001, Brain Research Bulletin.
[46] T. Dawson,et al. The role of nitric oxide in Parkinson's disease. , 2001, Methods in molecular medicine.
[47] N. Tatton. Increased Caspase 3 and Bax Immunoreactivity Accompany Nuclear GAPDH Translocation and Neuronal Apoptosis in Parkinson's Disease , 2000, Experimental Neurology.
[48] Jacqueline N. Crawley,et al. What's Wrong With My Mouse?: Behavioral Phenotyping of Transgenic and Knockout Mice , 2000 .
[49] Ted M. Dawson,et al. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease , 1999, Nature Medicine.
[50] C. Cotman,et al. Bcl-2 Facilitates Recovery from DNA Damage after Oxidative Stress , 1999, Experimental Neurology.
[51] S. Archer,et al. Measurement of nitric oxide in biological models , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[52] A. Brock,et al. A New Automated Method for Phenotyping Arylesterase (EC 3.1.1.2) Based Upon Inhibition of Enzymatic Hydrolysis of 4-Nitrophenyl Acetate by Phenyl Acetate , 1992, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
[53] G. Ellman,et al. Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.